
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Chronic outpatient management of myasthenia gravis including diagnosis confirmation, pyridostigmine titration, immunotherapy, thymectomy evaluation, and crisis prevention.">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/myasthenia-gravis/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Myasthenia Gravis - Outpatient Management - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#myasthenia-gravis-outpatient-management" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Myasthenia Gravis - Outpatient Management
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cidp/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    CIDP
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/diabetic-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Diabetic Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-chronic-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS Chronic Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Headache
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Headache
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/migraine/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Migraine
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cluster-headache/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cluster Headache
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/medication-overuse-headache/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Medication Overuse Headache
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_11" >
        
          
          <label class="md-nav__link" for="__nav_3_11" id="__nav_3_11_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Movement Disorders
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_11_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_11">
            <span class="md-nav__icon md-icon"></span>
            
  
    Movement Disorders
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/parkinsons-disease-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Parkinson's Disease - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/essential-tremor/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Essential Tremor
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/restless-legs-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Restless Legs Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_12" >
        
          
          <label class="md-nav__link" for="__nav_3_12" id="__nav_3_12_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Dementia & Cognitive
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_12_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_12">
            <span class="md-nav__icon md-icon"></span>
            
  
    Dementia & Cognitive
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/dementia-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Dementia Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_13" >
        
          
          <label class="md-nav__link" for="__nav_3_13" id="__nav_3_13_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Cranial Neuropathies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_13_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_13">
            <span class="md-nav__icon md-icon"></span>
            
  
    Cranial Neuropathies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bells-palsy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bell's Palsy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/trigeminal-neuralgia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Trigeminal Neuralgia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_14" >
        
          
          <label class="md-nav__link" for="__nav_3_14" id="__nav_3_14_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Intracranial Pressure
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_14_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_14">
            <span class="md-nav__icon md-icon"></span>
            
  
    Intracranial Pressure
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/idiopathic-intracranial-hypertension/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Idiopathic Intracranial Hypertension
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_15" >
        
          
          <label class="md-nav__link" for="__nav_3_15" id="__nav_3_15_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Metabolic & Nutritional
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_15_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_15">
            <span class="md-nav__icon md-icon"></span>
            
  
    Metabolic & Nutritional
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/wernicke-encephalopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Wernicke Encephalopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_16" >
        
          
          <label class="md-nav__link" for="__nav_3_16" id="__nav_3_16_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Syncope & Autonomic
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_16_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_16">
            <span class="md-nav__icon md-icon"></span>
            
  
    Syncope & Autonomic
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/syncope/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Syncope Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_17" >
        
          
          <label class="md-nav__link" for="__nav_3_17" id="__nav_3_17_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_17_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_17">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#section-a-action-items" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION A: ACTION ITEMS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#section-b-reference-expand-as-needed" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION B: REFERENCE (Expand as Needed)
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-mgfa-clinical-classification" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: MGFA Clinical Classification
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-thymectomy-decision-guide" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Thymectomy Decision Guide
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-c-treatment-algorithm" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX C: Treatment Algorithm
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-d-crisis-warning-signs-patient-handout" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX D: Crisis Warning Signs - Patient Handout
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:autoimmune" class="md-tag">autoimmune</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:chronic-management" class="md-tag">chronic-management</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:myasthenia-gravis" class="md-tag">myasthenia-gravis</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:neuromuscular" class="md-tag">neuromuscular</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:outpatient" class="md-tag">outpatient</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="myasthenia-gravis-outpatient-management">Myasthenia Gravis - Outpatient Management<a class="headerlink" href="#myasthenia-gravis-outpatient-management" title="Permanent link">&para;</a></h1>
<p><strong>VERSION:</strong> 1.0
<strong>CREATED:</strong> January 27, 2026
<strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>DIAGNOSIS:</strong> Myasthenia Gravis - Outpatient Management</p>
<p><strong>ICD-10:</strong> G70.00 (Myasthenia gravis without exacerbation), G70.01 (Myasthenia gravis with exacerbation)</p>
<p><strong>SYNONYMS:</strong> MG, myasthenia, autoimmune myasthenia gravis, ocular myasthenia, generalized myasthenia, AChR-positive MG, MuSK myasthenia, seronegative myasthenia, MG chronic management, MG maintenance therapy</p>
<p><strong>SCOPE:</strong> Outpatient diagnosis, management, and monitoring of myasthenia gravis in adults. Covers antibody-positive (AChR, MuSK, LRP4) and seronegative MG, ocular and generalized subtypes, pyridostigmine optimization, immunotherapy initiation and monitoring, thymectomy evaluation, and crisis prevention. Excludes myasthenic crisis (see "Myasthenia Gravis - Exacerbation/Crisis"), Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes, and drug-induced myasthenia.</p>
<hr />
<p><strong>KEY CLINICAL FEATURES:</strong>
- <strong>Fatigable weakness:</strong> Worsens with activity, improves with rest
- <strong>Ocular MG:</strong> Ptosis, diplopia; may remain ocular or generalize (50-80% generalize within 2 years)
- <strong>Generalized MG:</strong> Bulbar (dysarthria, dysphagia, facial weakness), limb (proximal &gt; distal), respiratory
- <strong>Diurnal variation:</strong> Worse later in day, better in morning
- <strong>MuSK MG:</strong> Prominent bulbar, neck, respiratory weakness; less ocular; poor response to pyridostigmine</p>
<p><strong>ANTIBODY SUBTYPES:</strong>
| Subtype | Frequency | Characteristics |
|---------|-----------|-----------------|
| <strong>AChR-positive</strong> | 85% of generalized, 50% of ocular | Typical MG; thymoma association; good pyridostigmine response |
| <strong>MuSK-positive</strong> | 40% of AChR-negative | Bulbar predominant; less ocular; poor pyridostigmine response; good rituximab response |
| <strong>LRP4-positive</strong> | ~2% of double-negative | Milder phenotype; overlap with AChR+ features |
| <strong>Seronegative</strong> | ~10-15% | May seroconvert; treat as AChR-positive; consider low-affinity antibodies |</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<hr />
<div class="admonition warning">
<p class="admonition-title">CRISIS PREVENTION</p>
<p><strong>Myasthenic crisis occurs in 15-20% of patients.</strong> Recognize warning signs (worsening bulbar/respiratory symptoms, declining FVC) and know medications to avoid. See Section 3E for medications that exacerbate MG.</p>
</div>
<div class="admonition info">
<p class="admonition-title">THYMECTOMY CONSIDERATION</p>
<p><strong>Thymectomy improves outcomes in non-thymomatous AChR+ generalized MG age 18-65.</strong> All patients need CT chest to evaluate for thymoma. See Section 4A for referral criteria.</p>
</div>
<hr />
<hr />
<h2 id="section-a-action-items">SECTION A: ACTION ITEMS<a class="headerlink" href="#section-a-action-items" title="Permanent link">&para;</a></h2>
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs-diagnostic-workup">1A. Essential/Core Labs - Diagnostic Workup<a class="headerlink" href="#1a-essentialcore-labs-diagnostic-workup" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>AChR binding antibody</td>
<td>Primary diagnostic test; positive in 85% generalized, 50% ocular MG</td>
<td>Positive confirms diagnosis</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>AChR modulating antibody</td>
<td>Increases sensitivity when combined with binding antibody</td>
<td>Positive supports diagnosis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>AChR blocking antibody</td>
<td>Additional AChR antibody; may be positive when binding negative</td>
<td>Positive supports diagnosis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MuSK antibody</td>
<td>Order if AChR negative; positive in ~40% of AChR-negative patients</td>
<td>Positive confirms MuSK MG</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>LRP4 antibody</td>
<td>Order if AChR and MuSK negative; available at specialized labs</td>
<td>Positive confirms LRP4 MG</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Anti-striated muscle antibody</td>
<td>Thymoma association; if positive, high likelihood of thymoma</td>
<td>Positive warrants urgent CT chest</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TSH</td>
<td>Autoimmune thyroid disease common comorbidity (10-15%)</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CBC with differential</td>
<td>Baseline before immunotherapy; infection assessment</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>CMP</td>
<td>Baseline renal/hepatic function; electrolytes</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>TPMT activity or genotype</td>
<td>Required before azathioprine initiation; low activity increases toxicity risk</td>
<td>Normal or intermediate activity</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hepatitis B surface antigen and core antibody</td>
<td>Before rituximab or other B-cell depleting therapy</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Hepatitis C antibody</td>
<td>Before immunosuppressive therapy</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Quantitative immunoglobulins (IgG, IgA, IgM)</td>
<td>Baseline before IVIg or rituximab; IgA deficiency is IVIg contraindication</td>
<td>Normal; IgA &gt;7 mg/dL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HIV antibody</td>
<td>Before immunosuppressive therapy</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Tuberculosis screen (QuantiFERON-Gold or PPD)</td>
<td>Before chronic immunosuppression</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fasting glucose and HbA1c</td>
<td>Baseline before chronic steroid therapy</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin D, 25-hydroxy</td>
<td>Steroid-induced osteoporosis prevention</td>
<td>&gt;30 ng/mL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Free T4</td>
<td>If TSH abnormal; autoimmune thyroid disease</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clustered AChR antibody assay</td>
<td>Seronegative MG; may detect low-affinity antibodies not seen on standard assay</td>
<td>Positive supports diagnosis in seronegative cases</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Paraneoplastic panel</td>
<td>Occult malignancy concern; particularly if anti-striated muscle positive</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cortisol (AM)</td>
<td>Adrenal insufficiency if on chronic steroids being tapered</td>
<td>Normal stress response</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ACTH stimulation test</td>
<td>Suspected secondary adrenal insufficiency from steroid withdrawal</td>
<td>Normal cortisol response</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Bone densitometry markers (CTX, P1NP)</td>
<td>Osteoporosis risk on chronic steroids</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CT chest with contrast</td>
<td>At diagnosis; exclude thymoma</td>
<td>No thymoma or thymic hyperplasia (or if present, surgical planning)</td>
<td>Contrast allergy, renal impairment (CrCl &lt;30)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>CT chest without contrast</td>
<td>If contrast contraindicated</td>
<td>Thymic abnormality assessment</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Repetitive nerve stimulation (RNS)</td>
<td>Diagnostic confirmation; if antibodies negative or for monitoring</td>
<td>Decremental response &gt;10% at 3 Hz (positive)</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Pulmonary function tests (FVC, NIF)</td>
<td>Baseline respiratory function; symptom correlation</td>
<td>FVC &gt;80% predicted; NIF more negative than -60 cmH2O</td>
<td>Facial weakness limiting seal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Single-fiber EMG (SFEMG)</td>
<td>Most sensitive test; if RNS and antibodies negative</td>
<td>Increased jitter and blocking</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRI chest</td>
<td>If CT indeterminate for thymoma; cystic thymic lesions</td>
<td>Characterize thymic mass</td>
<td>Pacemaker, severe claustrophobia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>PET-CT</td>
<td>Suspected thymoma malignancy or metastasis</td>
<td>No FDG-avid lesions</td>
<td>Pregnancy; hemodynamic instability</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ice pack test</td>
<td>Bedside diagnostic for ptosis; cooling improves neuromuscular transmission</td>
<td>Improvement in ptosis after 2 minutes of ice application</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Video swallow study</td>
<td>Dysphagia symptoms; aspiration risk assessment</td>
<td>Safe swallow; define texture modifications</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>DEXA scan</td>
<td>Chronic steroid exposure; osteoporosis screening</td>
<td>T-score &gt;-2.5</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Edrophonium (Tensilon) test</td>
<td>Rarely used now; if diagnostic uncertainty and other tests unavailable</td>
<td>Improvement in weakness within 30-60 seconds</td>
<td>Cardiac arrhythmia, asthma (relative)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sleep study (polysomnography)</td>
<td>Sleep-disordered breathing; respiratory weakness; fatigue</td>
<td>AHI &lt;5/hour; no nocturnal desaturation</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cardiac MRI</td>
<td>Suspected cardiac involvement (rare)</td>
<td>Normal</td>
<td>Pacemaker</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<h3 id="3a-cholinesterase-inhibitors-symptomatic-treatment">3A. Cholinesterase Inhibitors (Symptomatic Treatment)<a class="headerlink" href="#3a-cholinesterase-inhibitors-symptomatic-treatment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pyridostigmine</td>
<td>PO</td>
<td>First-line symptomatic treatment for all MG subtypes</td>
<td>30 mg TID; 60 mg TID; 60 mg QID; 90 mg QID :: PO :: :: Start 30 mg TID; increase by 30 mg/dose every 3-5 days as tolerated; usual maintenance 60 mg q4-6h (max 120 mg q4h); take 30-60 min before meals for swallowing</td>
<td>Mechanical bowel/bladder obstruction; known hypersensitivity</td>
<td>Cholinergic symptoms (SLUDGE: salivation, lacrimation, urination, defecation, GI distress, emesis); bradycardia; if symptoms occur, reduce dose</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Pyridostigmine SR (Mestinon Timespan)</td>
<td>PO</td>
<td>Nocturnal symptoms; morning weakness on awakening</td>
<td>180 mg qHS :: PO :: :: 180 mg at bedtime for nocturnal weakness; do NOT crush; erratic absorption limits daytime use; max 1 tablet daily</td>
<td>Same as immediate-release</td>
<td>Same as immediate-release</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Glycopyrrolate</td>
<td>PO</td>
<td>Cholinergic side effects from pyridostigmine</td>
<td>1 mg BID; 1 mg TID; 2 mg TID :: PO :: :: 1-2 mg PO BID-TID for secretions, diarrhea, or cramping from pyridostigmine; does not cross BBB</td>
<td>Glaucoma; severe cardiac disease; GI obstruction</td>
<td>Dry mouth; urinary retention; constipation; tachycardia</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>PYRIDOSTIGMINE DOSING GUIDANCE:</strong>
- <strong>Start low:</strong> 30 mg TID to assess response and tolerability
- <strong>Titrate slowly:</strong> Increase by 30 mg/dose every 3-5 days
- <strong>Time meals:</strong> Take 30-60 minutes before meals if dysphagia present
- <strong>MuSK MG:</strong> Often poor response; may worsen with high doses; use cautiously
- <strong>Overcorrection:</strong> Cholinergic crisis (SLUDGE symptoms, weakness, fasciculations) if overdosed</p>
<h3 id="3b-corticosteroids">3B. Corticosteroids<a class="headerlink" href="#3b-corticosteroids" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Prednisone (low-dose start)</td>
<td>PO</td>
<td>Ocular or mild generalized MG; outpatient initiation</td>
<td>10 mg daily; 20 mg daily; 30 mg daily; 40 mg daily :: PO :: :: Start 10-20 mg daily; increase by 10 mg every 5-7 days to target 1 mg/kg/day (max 60-80 mg); LOW-DOSE START prevents transient worsening in outpatient setting</td>
<td>Active untreated infection; psychosis (relative); poorly controlled diabetes</td>
<td>Glucose weekly during titration; BP; weight; mood; bone density annually</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Prednisone (high-dose)</td>
<td>PO</td>
<td>Hospital setting with crisis protection (post-IVIg/PLEX)</td>
<td>60 mg daily; 1 mg/kg daily :: PO :: :: 60-80 mg or 1 mg/kg daily; only start high-dose after IVIg/PLEX coverage in hospital or if admitted for monitoring</td>
<td>Active infection (relative); NOT FOR OUTPATIENT INITIATION</td>
<td>Glucose q6h; BP; K+; monitor for transient worsening days 5-10</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Prednisone (maintenance/taper)</td>
<td>PO</td>
<td>Chronic MG on stable steroids</td>
<td>Per taper schedule :: PO :: :: Once stable on target dose x 2-4 weeks, begin slow taper: reduce by 10 mg q2-4 weeks until 20 mg, then by 5 mg q2-4 weeks until 10 mg, then by 2.5 mg q month; may need minimum maintenance dose indefinitely</td>
<td>-</td>
<td>Symptoms of adrenal insufficiency during taper; flare</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<p><strong>STEROID WARNING:</strong> High-dose corticosteroids can cause transient worsening of MG (typically days 5-10).
- <strong>Outpatient initiation:</strong> ALWAYS start LOW (10-20 mg) and titrate slowly
- <strong>Hospital with IVIg/PLEX coverage:</strong> Can start high-dose since protected by immunotherapy
- Never stop steroids abruptly after &gt;2 weeks of therapy (adrenal suppression)</p>
<h3 id="3c-steroid-sparing-immunosuppressants-disease-modifying">3C. Steroid-Sparing Immunosuppressants (Disease-Modifying)<a class="headerlink" href="#3c-steroid-sparing-immunosuppressants-disease-modifying" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Pre-Treatment Requirements</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Azathioprine</td>
<td>PO</td>
<td>Steroid-sparing; first-line maintenance immunosuppressant</td>
<td>50 mg daily; 100 mg daily; 150 mg daily; 2-3 mg/kg daily :: PO :: :: Start 50 mg daily x 1-2 weeks; increase by 50 mg every 2-4 weeks to target 2-3 mg/kg/day (usually 150-200 mg/day); takes 6-12 months for full effect</td>
<td>TPMT genotype or enzyme activity; CBC; LFTs; hepatitis panel</td>
<td>TPMT deficiency (intermediate requires 50% dose reduction); pregnancy; concurrent allopurinol (75% dose reduction required)</td>
<td>CBC weekly x 4 weeks, then monthly x 3 months, then q3 months; LFTs monthly x 3 months, then q3 months; flu-like symptoms on initiation (hypersensitivity, discontinue)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Mycophenolate mofetil</td>
<td>PO</td>
<td>Steroid-sparing; alternative to azathioprine</td>
<td>500 mg BID; 1000 mg BID; 1500 mg BID :: PO :: :: Start 500 mg BID; increase to 1000 mg BID after 2 weeks; may increase to 1500 mg BID if needed; takes 3-6 months for effect</td>
<td>CBC; LFTs; hepatitis panel; pregnancy test</td>
<td>Pregnancy (teratogenic); breastfeeding; hypersensitivity</td>
<td>CBC every 2 weeks x 2 months, then monthly x 4 months, then q3 months; LFTs q3 months; GI side effects common</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Mycophenolate sodium (Myfortic)</td>
<td>PO</td>
<td>Alternative formulation with less GI side effects</td>
<td>360 mg BID; 720 mg BID :: PO :: :: Start 360 mg BID; increase to 720 mg BID; 720 mg = 1000 mg mycophenolate mofetil</td>
<td>Same as mycophenolate mofetil</td>
<td>Same as mycophenolate mofetil</td>
<td>Same as mycophenolate mofetil</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Tacrolimus</td>
<td>PO</td>
<td>Steroid-sparing; faster onset than azathioprine (3-6 months)</td>
<td>3 mg daily; 3 mg BID :: PO :: :: Start 3 mg daily; adjust to trough level 5-10 ng/mL; usual dose 3 mg BID; faster onset than azathioprine</td>
<td>Renal function; glucose; BP; drug interaction review</td>
<td>Renal impairment; uncontrolled hypertension; concurrent potassium-sparing diuretics</td>
<td>Tacrolimus trough level monthly; renal function monthly; glucose; BP; tremor; headache</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cyclosporine</td>
<td>PO</td>
<td>Alternative to tacrolimus; similar efficacy</td>
<td>3-5 mg/kg/day divided BID :: PO :: :: 3-5 mg/kg/day divided BID; adjust to trough 100-200 ng/mL</td>
<td>Renal function; BP; lipids</td>
<td>Renal impairment; uncontrolled hypertension; concurrent nephrotoxins</td>
<td>Cyclosporine trough monthly; renal function monthly; BP; lipids; gingival hyperplasia; hirsutism</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3d-biologic-and-targeted-immunotherapies">3D. Biologic and Targeted Immunotherapies<a class="headerlink" href="#3d-biologic-and-targeted-immunotherapies" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Pre-Treatment Requirements</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rituximab</td>
<td>IV</td>
<td>MuSK-positive MG (often first-line after steroids); refractory AChR+ MG</td>
<td>375 mg/m2 weekly x 4 weeks; 1000 mg q2 weeks x 2 :: IV :: :: Either 375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses (2 weeks apart); premedicate with methylprednisolone 100 mg, acetaminophen, diphenhydramine; repeat courses as needed</td>
<td>Hepatitis B screening (HBsAg, anti-HBc); quantitative immunoglobulins; TB screen</td>
<td>Active hepatitis B; active severe infection; live vaccines within 4 weeks</td>
<td>Infusion reactions; CD19/CD20 B-cell count q3-6 months; immunoglobulins annually; infection monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Eculizumab (Soliris)</td>
<td>IV</td>
<td>AChR+ refractory generalized MG; FDA approved</td>
<td>900 mg weekly x 4 weeks, then 1200 mg q2 weeks :: IV :: :: 900 mg IV weekly x 4 weeks (induction), then 1200 mg IV every 2 weeks (maintenance); infuse over 35 min</td>
<td>Meningococcal vaccination (MenACWY and MenB) at least 2 weeks before; REMS enrollment</td>
<td>Unresolved Neisseria meningitidis infection; not current with meningococcal vaccines</td>
<td>Meningococcal infection risk (BLACK BOX); infusion reactions; headache; URI</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ravulizumab (Ultomiris)</td>
<td>IV</td>
<td>AChR+ refractory generalized MG; longer dosing interval</td>
<td>Weight-based loading then maintenance q8 weeks :: IV :: :: Load: 40-60 kg: 2400 mg; 60-100 kg: 2700 mg; &gt;100 kg: 3000 mg; Maintenance q8 weeks: 40-60 kg: 3000 mg; 60-100 kg: 3300 mg; &gt;100 kg: 3600 mg</td>
<td>Meningococcal vaccination; REMS enrollment</td>
<td>Same as eculizumab</td>
<td>Same as eculizumab; less frequent infusions</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Efgartigimod (Vyvgart)</td>
<td>IV</td>
<td>AChR+ generalized MG; FcRn inhibitor; lowers IgG</td>
<td>10 mg/kg weekly x 4 weeks :: IV :: :: 10 mg/kg IV infusion over 1 hour weekly x 4 weeks per treatment cycle; repeat cycles as needed based on clinical response</td>
<td>Baseline immunoglobulins; infection screening</td>
<td>Active serious infection; IgG &lt;2 g/L (relative)</td>
<td>IgG levels; infection; infusion reactions; headache</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo)</td>
<td>SC</td>
<td>AChR+ generalized MG; subcutaneous administration</td>
<td>1008 mg SC weekly x 4 weeks :: SC :: :: 1008 mg SC injection weekly x 4 weeks per treatment cycle; self-administered at home after training</td>
<td>Same as IV efgartigimod</td>
<td>Same as IV efgartigimod</td>
<td>Same as IV efgartigimod; injection site reactions</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rozanolixizumab (Rystiggo)</td>
<td>SC</td>
<td>AChR+ generalized MG; FcRn inhibitor</td>
<td>420 mg SC weekly x 6 weeks :: SC :: :: 420 mg SC injection weekly x 6 weeks per treatment cycle; repeat cycles as needed</td>
<td>Baseline immunoglobulins; infection screening</td>
<td>Active serious infection</td>
<td>IgG levels; infection; pyrexia; headache; diarrhea</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Zilucoplan (Zilbrysq)</td>
<td>SC</td>
<td>AChR+ generalized MG; C5 complement inhibitor; daily SC</td>
<td>0.3 mg/kg daily :: SC :: :: 0.3 mg/kg SC daily; self-administered; meningococcal vaccination required</td>
<td>Meningococcal vaccination (MenACWY and MenB); REMS enrollment</td>
<td>Unresolved Neisseria infection</td>
<td>Meningococcal infection risk; injection site reactions; diarrhea; URI</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3e-medications-to-avoid-in-myasthenia-gravis">3E. Medications to AVOID in Myasthenia Gravis<a class="headerlink" href="#3e-medications-to-avoid-in-myasthenia-gravis" title="Permanent link">&para;</a></h3>
<p><strong>CRITICAL: These medications can worsen MG and precipitate crisis. Review all prescriptions before initiating.</strong></p>
<table>
<thead>
<tr>
<th>Category</th>
<th>Medications to AVOID</th>
<th>Safer Alternatives</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Antibiotics</strong></td>
<td>Aminoglycosides (gentamicin, tobramycin, amikacin, streptomycin); Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin); Macrolides (azithromycin, erythromycin, clarithromycin); Telithromycin (absolute contraindication)</td>
<td>Penicillins; Cephalosporins; Carbapenems; Sulfonamides; Vancomycin</td>
</tr>
<tr>
<td><strong>Cardiac medications</strong></td>
<td>Beta-blockers (propranolol, metoprolol, atenolol, carvedilol - ALL); Calcium channel blockers (verapamil, diltiazem); Class Ia antiarrhythmics (procainamide, quinidine, disopyramide); Lidocaine IV</td>
<td>ACE inhibitors; ARBs; Dihydropyridine CCBs (amlodipine, nifedipine) with caution</td>
</tr>
<tr>
<td><strong>Neuromuscular blockers</strong></td>
<td>Succinylcholine (prolonged paralysis); Non-depolarizing agents (prolonged effect)</td>
<td>If essential: reduced-dose rocuronium with sugammadex reversal available</td>
</tr>
<tr>
<td><strong>Psychiatric medications</strong></td>
<td>Lithium; Chlorpromazine and other phenothiazines; High-dose benzodiazepines</td>
<td>SSRIs (sertraline, escitalopram); Bupropion; Low-dose benzodiazepines with caution</td>
</tr>
<tr>
<td><strong>Anticonvulsants</strong></td>
<td>Phenytoin; Gabapentin (rare reports); Pregabalin (rare reports)</td>
<td>Levetiracetam; Valproate; Lamotrigine</td>
</tr>
<tr>
<td><strong>Magnesium</strong></td>
<td>IV magnesium sulfate (high dose); Magnesium-containing antacids (high dose)</td>
<td>If eclampsia: use with monitoring and intubation preparedness</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td>D-penicillamine (can induce MG); Botulinum toxin (any formulation); Quinine; Chloroquine/hydroxychloroquine; Iodinated contrast (use with caution); Checkpoint inhibitors (ipilimumab, nivolumab, pembrolizumab)</td>
<td>Document MG on chart; consult neurology before new medications</td>
</tr>
</tbody>
</table>
<h3 id="3f-supportive-care-and-comorbidities">3F. Supportive Care and Comorbidities<a class="headerlink" href="#3f-supportive-care-and-comorbidities" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Calcium + Vitamin D</td>
<td>PO</td>
<td>Bone protection on chronic steroids</td>
<td>Calcium 1000-1200 mg daily + Vitamin D 1000-2000 IU daily :: PO :: :: Calcium 500-600 mg BID with meals; Vitamin D 1000-2000 IU daily; target 25-OH Vitamin D &gt;30 ng/mL</td>
<td>Hypercalcemia; kidney stones</td>
<td>Vitamin D level annually; calcium as needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Bisphosphonate (Alendronate)</td>
<td>PO</td>
<td>Osteoporosis prevention/treatment on chronic steroids</td>
<td>70 mg weekly :: PO :: :: 70 mg PO weekly on empty stomach with full glass of water; remain upright 30 min; consider if steroids &gt;3 months at prednisone &gt;5 mg/day</td>
<td>GFR &lt;30-35; esophageal disorders; inability to remain upright</td>
<td>DEXA at baseline and q1-2 years; jaw osteonecrosis rare</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>PPI (Omeprazole)</td>
<td>PO</td>
<td>GI protection during high-dose steroids</td>
<td>20 mg daily; 40 mg daily :: PO :: :: 20-40 mg PO daily while on high-dose prednisone; consider tapering off when steroids reduced</td>
<td>Long-term use increases C. diff risk</td>
<td>Limit duration; consider H2 blocker alternative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Trimethoprim-sulfamethoxazole</td>
<td>PO</td>
<td>PJP prophylaxis if on high-dose steroids + other immunosuppression</td>
<td>1 DS tablet 3x weekly :: PO :: :: 1 DS tablet (160/800 mg) PO Monday/Wednesday/Friday; or 1 SS tablet daily</td>
<td>Sulfa allergy; G6PD deficiency</td>
<td>CBC periodically; rash</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neuromuscular specialist/MG center for diagnosis confirmation, treatment optimization, and clinical trial consideration</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Thoracic surgery consult for thymectomy evaluation in AChR+ generalized MG age 18-65 years without thymoma, or any patient with thymoma</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Pulmonology consult for baseline pulmonary function testing and ongoing respiratory monitoring in patients with respiratory symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Neuro-ophthalmology for diplopia management, prism prescription, or ptosis surgery evaluation in stable ocular MG</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Speech therapy for swallow evaluation given bulbar symptoms and aspiration risk assessment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Physical therapy for generalized weakness to maintain function and prevent deconditioning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Occupational therapy for ADL assessment and energy conservation strategies given fatigable weakness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rheumatology if concurrent autoimmune disease suspected (thyroid, lupus, rheumatoid arthritis)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Infusion center for IVIg, rituximab, eculizumab, or other IV immunotherapy administration</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>High-risk OB for pregnancy planning in women with MG given medication adjustments and delivery planning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Endocrinology for steroid-induced diabetes, osteoporosis, or adrenal insufficiency management</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Social work for disability planning, MG Foundation resources, and insurance navigation for expensive biologics</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Psychiatry for depression or anxiety related to chronic illness or steroid side effects</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Return immediately if worsening weakness, breathing difficulty, or difficulty swallowing develops (may indicate crisis requiring hospitalization)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Carry MG medical alert card or bracelet listing diagnosis and medications to avoid (aminoglycosides, fluoroquinolones, beta-blockers, magnesium)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not stop prednisone or immunosuppressants abruptly; sudden discontinuation may trigger exacerbation or adrenal crisis</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Take pyridostigmine 30-60 minutes before meals to improve swallowing and reduce choking risk during eating</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Report fever or signs of infection promptly as immunosuppression increases infection risk and infection can trigger MG exacerbation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid extreme heat as high temperatures worsen neuromuscular transmission and increase weakness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not drive if diplopia or ptosis impairs vision; symptoms may fluctuate throughout the day</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid overexertion; pace activities throughout the day with rest periods to manage fatigable weakness</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Report new medications (including over-the-counter) to neurologist before taking, as many common drugs worsen MG</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Women: Discuss pregnancy plans with MG specialist in advance as medication adjustments are needed before conception</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Contact Myasthenia Gravis Foundation of America (www.myasthenia.org) for patient support, educational resources, and community</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Report symptoms of cholinergic overdose: excessive secretions, diarrhea, cramping, muscle twitching, bradycardia (reduce pyridostigmine dose)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Medication reconciliation before any new prescription to avoid MG-exacerbating drugs; bring medication list to all appointments</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid live vaccines while on immunosuppression (azathioprine, mycophenolate, rituximab, high-dose steroids); inactivated vaccines are safe</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Annual influenza vaccine (inactivated) to prevent respiratory infections that can trigger exacerbation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Pneumococcal vaccination (PCV15 or PCV20 + PPSV23) before starting immunosuppression</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Aspiration precautions including upright positioning during and after meals, small bites, and avoiding mixed textures if bulbar symptoms present</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Energy conservation techniques including pacing activities, scheduled rest periods, and prioritizing important tasks for morning</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid smoking as respiratory infections worsen MG and smoking reduces treatment efficacy</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Limit alcohol intake as it can worsen weakness and interact with medications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Stress management as psychological stress can trigger MG exacerbations</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Good sleep hygiene as fatigue and sleep deprivation worsen MG symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Wear medical alert identification listing MG diagnosis and medications to avoid in emergencies</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Weight management to reduce respiratory load and minimize steroid side effects</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<hr />
<h2 id="section-b-reference-expand-as-needed">SECTION B: REFERENCE (Expand as Needed)<a class="headerlink" href="#section-b-reference-expand-as-needed" title="Permanent link">&para;</a></h2>
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lambert-Eaton myasthenic syndrome (LEMS)</td>
<td>Proximal weakness improves with exercise; autonomic symptoms (dry mouth); SCLC association; areflexia</td>
<td>VGCC antibody; EMG with incremental response; CT chest for malignancy</td>
</tr>
<tr>
<td>Botulism</td>
<td>Descending paralysis; fixed dilated pupils; GI symptoms; recent wound or food exposure</td>
<td>Stool/serum toxin assay; EMG (incremental response); clinical history</td>
</tr>
<tr>
<td>Oculopharyngeal muscular dystrophy</td>
<td>Ptosis, dysphagia; slowly progressive; no fluctuation; onset &gt;45 years; family history</td>
<td>Genetic testing (GCN repeat in PABPN1); muscle biopsy</td>
</tr>
<tr>
<td>Thyroid eye disease</td>
<td>Proptosis; lid retraction (not ptosis); restrictive ophthalmopathy; thyroid dysfunction</td>
<td>TSH, free T4; orbital CT/MRI (extraocular muscle enlargement)</td>
</tr>
<tr>
<td>Chronic progressive external ophthalmoplegia (CPEO)</td>
<td>Slowly progressive ptosis and ophthalmoparesis; no fluctuation; may have systemic features</td>
<td>Muscle biopsy; mitochondrial DNA analysis; lactate</td>
</tr>
<tr>
<td>Miller Fisher syndrome</td>
<td>Ataxia, areflexia, ophthalmoplegia; post-infectious; acute onset</td>
<td>Anti-GQ1b antibody; CSF (albuminocytologic dissociation)</td>
</tr>
<tr>
<td>Brainstem lesion (stroke, tumor, MS)</td>
<td>Cranial nerve palsies; other brainstem signs; no fatigability</td>
<td>MRI brain with contrast</td>
</tr>
<tr>
<td>Guillain-Barre syndrome</td>
<td>Ascending weakness; areflexia; no fluctuation; sensory symptoms</td>
<td>CSF (elevated protein); EMG/NCS (demyelinating pattern)</td>
</tr>
<tr>
<td>Amyotrophic lateral sclerosis (ALS)</td>
<td>Upper and lower motor neuron signs; fasciculations; no fatigability; progressive</td>
<td>EMG (denervation); no antibodies; clinical criteria</td>
</tr>
<tr>
<td>Drug-induced myasthenia</td>
<td>Temporal relationship to D-penicillamine, checkpoint inhibitors, aminoglycosides</td>
<td>Medication history; may have positive AChR antibodies</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>CLINICAL</strong></td>
<td></td>
<td></td>
<td></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
</tr>
<tr>
<td>MG composite or QMG score</td>
<td>Every visit</td>
<td>Stable or improved</td>
<td>Escalate therapy if worsening</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Forced vital capacity (FVC)</td>
<td>Baseline; q3-6 months if respiratory symptoms; urgent if symptoms worsen</td>
<td>&gt;80% predicted; &gt;15 mL/kg</td>
<td>If FVC declining: hospitalize, consider IVIg/PLEX</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Negative inspiratory force (NIF)</td>
<td>With FVC; if respiratory symptoms</td>
<td>More negative than -60 cmH2O</td>
<td>If NIF &gt;-20 cmH2O: crisis, intubate</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Swallow function</td>
<td>Each visit if bulbar symptoms</td>
<td>Safe swallow</td>
<td>Modified diet; speech therapy; consider PEG if severe</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Weight</td>
<td>Each visit</td>
<td>Stable</td>
<td>Monitor steroid side effects; nutritional assessment if losing</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td><strong>LABORATORY</strong></td>
<td></td>
<td></td>
<td></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
</tr>
<tr>
<td>CBC with differential</td>
<td>Weekly x 4 then monthly x 3 then q3 months (azathioprine/MMF)</td>
<td>WBC &gt;3000; ALC &gt;500; Plt &gt;100K</td>
<td>Hold immunosuppressant if low; may resume at lower dose</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>LFTs</td>
<td>Monthly x 3 then q3 months</td>
<td>AST/ALT &lt;3x ULN</td>
<td>Reduce dose or discontinue if &gt;3x with symptoms</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Glucose</td>
<td>Weekly during steroid titration; q3 months on maintenance</td>
<td>Fasting &lt;126; random &lt;200</td>
<td>Initiate diabetes treatment if elevated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Blood pressure</td>
<td>Each visit</td>
<td>&lt;130/80 mmHg (steroid hypertension)</td>
<td>Antihypertensive if elevated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TPMT level/genotype</td>
<td>Once before azathioprine</td>
<td>Normal activity</td>
<td>Reduce dose 50% if intermediate; avoid if deficient</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Tacrolimus trough</td>
<td>Monthly if on tacrolimus</td>
<td>5-10 ng/mL</td>
<td>Dose adjustment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Immunoglobulins (IgG, IgA, IgM)</td>
<td>Baseline; annually on rituximab or anti-CD20</td>
<td>IgG &gt;400 mg/dL</td>
<td>Consider IVIG replacement if low and recurrent infections</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>B-cell count (CD19/CD20)</td>
<td>q3-6 months on rituximab</td>
<td>Depleted initially; document recovery</td>
<td>Guide re-dosing</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td><strong>BONE HEALTH</strong></td>
<td></td>
<td></td>
<td></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
<td style="text-align: center;"></td>
</tr>
<tr>
<td>DEXA scan</td>
<td>Baseline; q1-2 years if on chronic steroids</td>
<td>T-score &gt;-2.5</td>
<td>Bisphosphonate if osteopenia/osteoporosis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin D, 25-OH</td>
<td>Baseline; annually</td>
<td>&gt;30 ng/mL</td>
<td>Supplement if low</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Manage outpatient</strong></td>
<td>Stable ocular or mild generalized MG; FVC &gt;60% and stable; able to swallow safely; no respiratory symptoms; reliable follow-up</td>
</tr>
<tr>
<td><strong>Admit to floor</strong></td>
<td>Moderate-severe worsening not requiring ICU; initiation of high-dose steroids with IVIg/PLEX coverage; significant bulbar symptoms with aspiration risk; FVC 30-60% and declining; new diagnosis with moderate severity</td>
</tr>
<tr>
<td><strong>Admit to ICU</strong></td>
<td>FVC &lt;30% or rapidly declining; NIF weaker than -30 cmH2O; impending respiratory failure; severe bulbar dysfunction with aspiration; need for intubation or BiPAP</td>
</tr>
<tr>
<td><strong>Emergency evaluation</strong></td>
<td>Acute worsening of weakness; new respiratory symptoms (dyspnea, orthopnea); difficulty swallowing or speaking; recent infection or medication change with weakness; FVC declining on outpatient checks</td>
</tr>
<tr>
<td><strong>Transfer to MG center</strong></td>
<td>Refractory MG not responding to standard therapy; thymectomy evaluation; clinical trial consideration; complex immunotherapy decisions</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pyridostigmine for symptomatic treatment of MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/25304970/">Mehndiratta MM et al. Cochrane 2014</a></td>
</tr>
<tr>
<td>Thymectomy improves outcomes in AChR+ generalized MG age 18-65</td>
<td>Class I, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27509100/">Wolfe GI et al. NEJM 2016 (MGTX Trial)</a></td>
</tr>
<tr>
<td>Corticosteroids effective for MG</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16034852/">Schneider-Gold C et al. Cochrane 2005</a></td>
</tr>
<tr>
<td>Azathioprine as steroid-sparing agent</td>
<td>Class I, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/9771070/">Palace J et al. NEJM 1998</a></td>
</tr>
<tr>
<td>Mycophenolate mofetil in MG (mixed evidence)</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27438060/">Sanders DB et al. Muscle Nerve 2016</a></td>
</tr>
<tr>
<td>Rituximab effective in MuSK-positive MG</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/34986310/">Nowak RJ et al. Neurology 2022</a></td>
</tr>
<tr>
<td>Rituximab in refractory AChR+ MG</td>
<td>Class II, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27463434/">Tandan R et al. Muscle Nerve 2017</a></td>
</tr>
<tr>
<td>Eculizumab for refractory generalized AChR+ MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28969986/">Howard JF et al. Lancet Neurol 2017 (REGAIN)</a></td>
</tr>
<tr>
<td>Efgartigimod for generalized AChR+ MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/34146511/">Howard JF et al. Lancet Neurol 2021 (ADAPT)</a></td>
</tr>
<tr>
<td>Medications that exacerbate MG</td>
<td>Class III, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15257515/">Juel VC. Semin Neurol 2004</a></td>
</tr>
<tr>
<td>AAN/MGFA guidelines for MG management</td>
<td>Expert consensus</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/27386767/">Sanders DB et al. Neurology 2016</a></td>
</tr>
<tr>
<td>Ocular MG: 50-80% generalize within 2 years</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/12975292/">Kupersmith MJ et al. Arch Neurol 2003</a></td>
</tr>
<tr>
<td>Low-dose steroid initiation prevents worsening</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/12865163/">Pascuzzi RM. Semin Neurol 2003</a></td>
</tr>
<tr>
<td>Anti-striated muscle antibody and thymoma association</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15956157/">Romi F et al. Arch Neurol 2005</a></td>
</tr>
<tr>
<td>Ravulizumab for generalized AChR+ MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/36129997/">Vu T et al. NEJM 2022 (CHAMPION-MG)</a></td>
</tr>
<tr>
<td>Rozanolixizumab for generalized AChR+ MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/37385280/">Bril V et al. Lancet Neurol 2023</a></td>
</tr>
<tr>
<td>Zilucoplan for generalized AChR+ MG</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/37863588/">Howard JF et al. Lancet Neurol 2023 (RAISE)</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 27, 2026)</strong>
- Initial template creation for MG outpatient management
- Comprehensive antibody subtype overview (AChR, MuSK, LRP4, seronegative)
- Pyridostigmine dosing with structured format for order sentences
- Corticosteroid initiation protocols (low-dose outpatient vs high-dose inpatient)
- Steroid-sparing agents with pre-treatment and monitoring requirements
- All FDA-approved MG biologics (eculizumab, ravulizumab, efgartigimod, rozanolixizumab, zilucoplan)
- Comprehensive medications to avoid list
- Thymectomy indications and referral criteria
- Crisis prevention and warning signs
- PubMed citations verified for all evidence statements</p>
<hr />
<h2 id="appendix-a-mgfa-clinical-classification">APPENDIX A: MGFA Clinical Classification<a class="headerlink" href="#appendix-a-mgfa-clinical-classification" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Class</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>I</strong></td>
<td>Ocular weakness only (ptosis, diplopia)</td>
</tr>
<tr>
<td><strong>II</strong></td>
<td>Mild generalized weakness +/- ocular</td>
</tr>
<tr>
<td><strong>IIa</strong></td>
<td>Predominantly limb/axial</td>
</tr>
<tr>
<td><strong>IIb</strong></td>
<td>Predominantly oropharyngeal/respiratory</td>
</tr>
<tr>
<td><strong>III</strong></td>
<td>Moderate generalized weakness +/- ocular</td>
</tr>
<tr>
<td><strong>IIIa</strong></td>
<td>Predominantly limb/axial</td>
</tr>
<tr>
<td><strong>IIIb</strong></td>
<td>Predominantly oropharyngeal/respiratory</td>
</tr>
<tr>
<td><strong>IV</strong></td>
<td>Severe generalized weakness +/- ocular</td>
</tr>
<tr>
<td><strong>IVa</strong></td>
<td>Predominantly limb/axial</td>
</tr>
<tr>
<td><strong>IVb</strong></td>
<td>Predominantly oropharyngeal/respiratory</td>
</tr>
<tr>
<td><strong>V</strong></td>
<td>Intubation required (with or without mechanical ventilation)</td>
</tr>
</tbody>
</table>
<p><strong>Clinical Use:</strong> Document at diagnosis and follow changes. Class IIb, IIIb, IVb (bulbar predominant) have higher aspiration and crisis risk.</p>
<hr />
<h2 id="appendix-b-thymectomy-decision-guide">APPENDIX B: Thymectomy Decision Guide<a class="headerlink" href="#appendix-b-thymectomy-decision-guide" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Factor</th>
<th>Favors Thymectomy</th>
<th>Against/Defer</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Antibody status</strong></td>
<td>AChR-positive</td>
<td>MuSK-positive (poor evidence); seronegative (limited data)</td>
</tr>
<tr>
<td><strong>Age</strong></td>
<td>18-65 years (MGTX data)</td>
<td>&lt;18 or &gt;65 (less evidence, still consider)</td>
</tr>
<tr>
<td><strong>MG type</strong></td>
<td>Generalized MG</td>
<td>Ocular MG (controversial; consider if not responding to treatment or generalizing)</td>
</tr>
<tr>
<td><strong>Thymoma</strong></td>
<td>ALL thymomas require resection regardless of MG severity</td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Disease stability</strong></td>
<td>Stable enough for surgery</td>
<td>Actively worsening; optimize with IVIg/PLEX first</td>
</tr>
<tr>
<td><strong>Comorbidities</strong></td>
<td>Good surgical candidate</td>
<td>Poor surgical risk</td>
</tr>
</tbody>
</table>
<p><strong>MGTX Trial Key Findings:</strong>
- Thymectomy + prednisone superior to prednisone alone over 3 years
- Lower prednisone requirements
- Fewer immunosuppressants needed
- Fewer exacerbations
- Benefits persist at 5-year follow-up</p>
<hr />
<h2 id="appendix-c-treatment-algorithm">APPENDIX C: Treatment Algorithm<a class="headerlink" href="#appendix-c-treatment-algorithm" title="Permanent link">&para;</a></h2>
<div class="highlight"><pre><span></span><code>NEW DIAGNOSIS CONFIRMED
        |
        v
+------------------+
| Ocular MG only?  |
+------------------+
    |         |
   YES        NO
    |         |
    v         v
Pyridostigmine    Pyridostigmine + CT chest (thymoma screen)
    |                      |
    v                      v
Symptoms controlled?   +-------------------+
    |         |        | Thymoma present? |
   YES        NO       +-------------------+
    |         |            |         |
    v         v           YES        NO
Monitor for    Add            |         |
generalization prednisone     v         v
               (low-dose   Thymectomy  Age 18-65, AChR+?
               start)       urgent     Generalized?
    |              |                      |         |
    v              v                     YES        NO
If generalizes,  Taper steroids;        |         |
treat as         add steroid-           v         v
generalized      sparing agent      Consider    Steroids +
                 (AZA or MMF)       thymectomy  steroid-sparing
                       |                        (skip surgery)
                       v
              Stable on minimal steroids?
                    |         |
                   YES        NO
                    |         |
                    v         v
              Continue    Escalate:
              monitoring  Rituximab (esp MuSK+)
                          OR Complement inhibitor
                          OR FcRn inhibitor
</code></pre></div>
<hr />
<h2 id="appendix-d-crisis-warning-signs-patient-handout">APPENDIX D: Crisis Warning Signs - Patient Handout<a class="headerlink" href="#appendix-d-crisis-warning-signs-patient-handout" title="Permanent link">&para;</a></h2>
<p><strong>SEEK IMMEDIATE MEDICAL ATTENTION IF YOU EXPERIENCE:</strong></p>
<ul>
<li>Difficulty breathing or feeling short of breath</li>
<li>Trouble swallowing or choking on food/liquids/pills</li>
<li>Difficulty speaking (slurred or nasal speech) that is new or worsening</li>
<li>Weakness that is rapidly getting worse</li>
<li>Fever or signs of infection (infections can trigger crisis)</li>
<li>Recent exposure to medications on the "avoid" list</li>
</ul>
<p><strong>WARNING SIGNS OF IMPENDING CRISIS:</strong></p>
<ul>
<li>Increasing difficulty breathing when lying flat</li>
<li>Needing more pillows to sleep</li>
<li>Waking up short of breath at night</li>
<li>Feeling you can't take a deep breath</li>
<li>Voice becoming weaker or more nasal</li>
<li>Difficulty clearing throat or coughing effectively</li>
<li>Meals taking much longer due to swallowing difficulty</li>
<li>Choking episodes increasing</li>
<li>Needing to use neck muscles to breathe</li>
</ul>
<p><strong>WHAT TO DO:</strong></p>
<ol>
<li>Go to emergency department immediately (do not wait for clinic appointment)</li>
<li>Bring your medication list and MG card</li>
<li>Tell staff you have myasthenia gravis</li>
<li>Ask them to contact your neurologist</li>
<li>Request they avoid medications on your avoid list</li>
</ol>
<hr />
<div id="comments-container"></div>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>